[1] Cao M, Li H, Sun D.Cancer burden of major cancers in China: A need for sustainable actions[J]. Cancer Commun (Lond), 2020, 40(5): 205-210. [2] Wu H, Mu X, Liu L, et al.Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1[J]. Cell Death Dis, 2020, 11(9): 801. [3] Meng J, Chang C, Chen Y, et al.EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC[J]. Onco Targets Ther, 2019, 12: 6033-6043. [4] Miller KD, Siegel RL, Lin CC, et al.Cancer treatment and survivorship statistics, 2016[J]. CA Cancer J Clin, 2016, 66(4): 271-289. [5] Panneerselvam J, Mohandoss P, Patel R, et al.DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4[J]. Mol Ther Oncolytics, 2020, 18: 24-36. [6] Chen L, Wu C, Wang H, et al.Analysis of Long Noncoding RNAs in Aila-Induced Non-Small Cell Lung Cancer Inhibition[J]. Front Oncol, 2021, 11: 652567. [7] Zhuo Z, Hu J, Yang X, et al.Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo[J]. Sci Rep, 2015, 5: 16185. [8] 魏立璇,孙涛,马艳菊,等. 臭椿酮抑制ENST00000441270/miR-149轴影响结直肠癌细胞增殖和凋亡的实验研究[J]. 中华实验外科杂志,2021,38(2):230-234. [9] Chen L, Wu C, Wang H, et al.Analysis of Long Noncoding RNAs in Aila-Induced Non-Small Cell Lung Cancer Inhibition[J]. Front Oncol, 2021, 11: 652567. [10] 皇甫娟,张强,魏祯瑶,等. 基于p53介导自噬通路探讨臭椿酮对顺铂耐药胃癌细胞株耐药性的影响[J].现代药物与临床,2021,36(6):1112-1118. [11] Chou TC.Drug combination studies and their synergy quantification using the Chou-Talalay method[J].Cancer Res, 2010, 70(2): 440-446. [12] Liao XZ, Gao Y, Sun LL, et al.Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway[J]. Phytother Res, 2020, 34(5): 1142-1153. [13] Sun CY, Zhu Y, Li XF, et al.Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways[J]. Front Pharmacol, 2018, 9: 92. [14] Fan CC, Tsai ST, Lin CY, et al.EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis[J]. Redox Biol, 2020, 34: 101571. [15] Yu N, Xiong Y, Wang C.Bu-Zhong-Yi-Qi Decoction, the Water Extract of Chinese Traditional Herbal Medicine, Enhances Cisplatin Cytotoxicity in A549/DDP Cells through Induction of Apoptosis and Autophagy[J]. Biomed Res Int, 2017, 3692797. [16] 王浩,段佩雯,伏杰,等. 中药单体调控自噬逆转肿瘤耐药的实验研究现状[J]. 中医药导报,2019,25(13):53-56. [17] 田艳,冼乐武. 臭椿酮对非小细胞肺癌细胞生物学特性的影响及机制研究[J]. 河北中医,2019,41(2):268-274. [18] Yu W, Zhang X, Zhang W, et al.19-Hydroxybufalin inhibits non-small cell lung cancer cell proliferation and promotes cell apoptosis via the Wnt/β-catenin pathway[J]. Exp Hematol Oncol, 2021, 10(1): 48. [19] Wang R, Lu Y, Li H, et al.Antitumor activity of the Ailanthus altissima bark phytochemical ailanthone against breast cancer MCF-7 cells[J]. Oncol Lett, 2018;15(4): 6022-6028. [20] Yang X, Zheng F, Xing H, et al.Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer[J]. Cancer Res Clin Oncol, 2004, 130(7): 423-428. [21] 银瑞,董新伟,王铮. 顺铂诱导食管癌EC9706耐药细胞中Bcl-2的表达[J]. 中国老年学杂志,2016,36(3):562-564. [22] Chami M, Prandini A, Campanella M, et al.Bcl-2 and Bax exert opposing effects on Ca2+ signaling, which do not depend on their putative pore-forming region[J]. Biol Chem, 2004, 279(52): 54581-54589. |